Justice Dept. Approves Paramount’s Acquisition of Warner Bros. Discovery
The DOJ approved Paramount’s $111 billion takeover of Warner Bros.
Investor topic hub
Policy
Central banks, fiscal policy, tariffs, trade, sanctions, regulation, courts, and public decisions that can move the economy.
Federal Reserve and central-bank signals
Tariffs, trade, and sanctions
Regulation, investigations, and fiscal decisions
UK Vows to Phase Out Russian Diesel and Jet Fuel Imports By New Year
The UK commits to banning diesel and jet fuel imports refined from Russian crude by January 1, 2027, under sanctions for the war in Ukraine.
Private Sector Adds 122,000 Jobs in May, Exceeding Expectations, ADP Reports
The private sector added 122,000 jobs in May, exceeding expectations.
President Donald Trump Accelerates Psychedelic Research for Mental Health Treatment
President Donald Trump signed an executive order to accelerate research into psychedelic drugs for mental illness.
US CEOs Turn Pessimistic, Forecast Worsening Economy and Reduced Hiring in Q2 2026
US corporate leaders' confidence has plummeted, with many expecting economic conditions to worsen over the next six months.
California’s Exodus Fuels Florida ‘Gold Rush’ Amid Economic Strain and Wealth Migration
California's economic challenges, including high taxes and costs, are prompting a significant exodus of wealthy residents and businesses, leading to a 'gold rush' in...
Bari Weiss Initiates Major Overhaul of CBS’s ’60 Minutes,’ Replacing Key Personnel
CBS News Editor-in-Chief Bari Weiss is enacting major changes at '60 Minutes,' replacing its executive producer and several correspondents as part of a strategic...
Royal Mail Misses Delivery Targets Again, Faces Scrutiny Under New Ownership
Royal Mail's latest report shows only 75.7% of first-class mail delivered on time, missing its 93% target.
EU Fines Temu €200 Million for Selling Illegal and Dangerous Products
The EU has fined online retailer Temu €200 million for allowing illegal and dangerous products, such as faulty chargers and hazardous baby toys, to...
Replimune to Resubmit Melanoma Drug After FDA Leadership Change
Replimune is resubmitting its melanoma drug to the FDA for approval after two rejections, following a leadership change at the agency.